Naila Siddiqi
Pediatrics · Houston, TXNPI 1750371167
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $205 and has fallen 59.3% since, to $83 in 2025.
Across 48 payments — averaging $22.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$191
- AbbVie$180
- Novo Nordisk$160
- Cranial Technologies, Inc$104
- Lilly USA, LLC$90
- AstraZeneca$58
- plus $288 from 11 others
Across 220 payments — averaging $2914.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$362K
- Merck$151K
- Pfizer$73K
- Sanofi Pasteur Inc.$28K
- GSK$27K
What the payments were for
- Food & beverage$1,070100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 5 | $191 |
| AbbVie(2 entities) | 10 | $180 |
| Novo Nordisk | 3 | $160 |
| Cranial Technologies, Inc | 7 | $104 |
| Lilly USA, LLC | 5 | $90 |
| AstraZeneca | 3 | $58 |
| Merck | 4 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Pfizer | 1 | $28 |
| Exact Sciences | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $18 |
| Eisai Inc. | 1 | $14 |
How this compares
$1,070 in reported general payments places this provider in the 85th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Houston
- Pedro PiedraHouston$729K
- Vernon SuttonHouston$90K
- Carlos BacinoHouston$53K
- Farida AbidHouston$50K
- Lindsay CameronHouston$32K
- Juan Torres SanchezHouston$31K
- Martin YudovichHouston$24K
- Raegan HuntHouston$23K
- Michael PickettHouston$14K
- Lara LeonhardtHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.